A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2549652
The present invention provides a method of treating tumor in a patient comprising administering to said patient a CD40 agonist antibody according to an intermittent dosing schedule. The present invention also provides a method of treating tumor in a patient comprising administering a combination of a CD40 agonist antibody and a DNA replication inhibitor. Also provided is a formulation for use in the treatment.
Selon cette méthode de traitement de tumeurs chez un patient, on administre au patient un anticorps agoniste de CD40 selon un plan d'administration intermittente. L'invention concerne également une méthode de traitement de tumeurs chez un patient qui comprend l'administration d'une combinaison d'un anticorps agoniste de CD40 et d'un inhibiteur de la réplication de l'ADN, ainsi qu'une formulation utilisée dans le traitement.
Bedian Vahe
Cusmano John Daniel
Gladue Ronald Paul
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Cd40 antibody formulation and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd40 antibody formulation and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd40 antibody formulation and methods will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1823491